Benefits

The benefits of DERP membership include providing a collaborative network for policy makers to share information, and obtaining the best available evidence on effectiveness and safety comparisons between drugs to drive policymaking decisions.  The following evidence & policy tools are provided to Participating Organizations:

• Comprehensive, updated and unbiased systematic reviews regarding drug effectiveness and safety.  
• DERP members select the drug classes for systematic review.
• DERP members determine the timing of updating each report.
• In collaboration with the EPC, DERP members determine the key questions that guide each review. These elements allow the Participating Organizations to be responsive to the needs of their individual populations. 
• Summary documents of full systematic reviews (including executive summaries and P&T Committee briefs) that are not available to the public.
• Access to the DERP proprietary website that houses all DERP documents for easy, 24-hour-a-day retrieval.
• Monthly teleconference meetings for authors to present review findings, accompanied by a power point presentation.
• Bi-annual in person governance meetings to share experiences, present findings, and make decisions regarding the ongoing DERP project direction.

Additionally, DERP staff provides the following services:

• Response to all pharmaceutical company inquiries regarding the systematic review process.
• An on-site orientation to new Participating Organizations to introduce and explain the project to local staff and policy makers.
• Individual presentations at P&T Committees (for an additional fee).